
Nicolaus Andratschke
@nandratschke
ID: 1054590211706048512
23-10-2018 04:27:54
39 Tweet
131 Followers
43 Following

New article alert Jonas Willmann et al. Evaluation of the prognostic value of the ESTRO EORTC classification of oligometastatic disease in patients treated with stereotactic body radiotherapy: A retrospective single center study. doi.org/10.1016/j.rado… thegreenjournal.com/article/S0167-…




Just published! Proud to be part of this amazing group Ane Appelt Jonas Willmann, MD Nicolaus Andratschke ESTRO and EORTC consensus on re-irradiation: definition, reporting, and decision making ESTRO EORTC #radonc #OncoAlert OncoAlert The Lancet Oncology authors.elsevier.com/c/1fpnb5EIIgH-…



Today, on our TrueBeam 1001 we produced an eFlash beam with 1Gy per pulse in the isocenter Unispital_USZ Universität Zürich. Thanks to the Varian team for a great collaboration. We are looking forward to our eFlash research program #FlashRT #FlashRadiationTherapy #medphys #radonc




30 days to go! Join us live in Zurich Unispital_USZ on June 15: 👉Farewell Symposium for Prof. Dr. Stephan Bodis usz.ch/en/event/farew… 👉Reirradiation Symposium usz.ch/veranstaltung/… Don't forget to register for this exciting, international day Radio-Onkologie USZ Comprehensive Cancer Center Zurich !



(1/n) PROSPECT – important study of high quality & relevance for rectal cancer pts nejm.org/doi/full/10.10… HOWEVER, misleading & dangerous interpretation of The New York Times „brutal effects of RT“ nytimes.com/2023/06/04/hea…



We are delighted to announce that the first site for #ReCare, a cohort of the #E2RADIatE platform, has been activated. More: project.eortc.org/e2-radiate/202… @WBA_Global, Nicolaus Andratschke, Jonas Willmann, MD, Nieder Carsten, #CancerResearch #ClinicalTrials #Oncology
